RGBPRegen BioPharma Incvs its industry peers
A metric-by-metric comparison of Regen BioPharma Inc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RGBP본 종목 | — | — | — | — | 0.0%#7 | -90.7%#6 | -143.1%#4 | — | — | — | — | — |
| RANI | $149M#3 | — | 3.8x#2 | 91.3x#2 | 58.9%#2 | 1.1%#4 | -2346.0%#8 | -75.6%#5 | — | — | — | — |
| RDHL | $29.7B#1 | — | — | 3691.2x#3 | 23.2%#3 | -134.6%#9 | -181.7%#6 | — | — | — | — | — |
| RDPTF | — | — | — | — | 1114.3%#1 | 20.0%#1 | -1050.6%#7 | — | — | — | — | — |
| RDY | $10.2B#2 | — | 2.6x#1 | 2.7x#1 | 13.8%#4 | — | 22.1%#3 | 17.0%#1 | — | — | — | 0.8%#1 |
| REGN | — | 19.4x#1 | — | — | 1.0%#6 | 2.1%#3 | 24.9%#2 | 14.2%#2 | 9.4%#1 | — | 31.2%#1 | — |
| RFL | — | — | — | — | — | 11.3%#2 | -97196.7%#9 | -40.5%#4 | -43.7%#3 | — | — | — |
| RGBPP | — | — | — | — | 0.0%#7 | -90.7%#6 | -143.1%#4 | — | — | — | — | — |
| RMHI | — | — | — | — | — | -116.8%#8 | — | — | — | — | — | — |
| RPRX | — | 31.3x#2 | — | — | 5.1%#5 | -10.2%#5 | 65.6%#1 | 7.9%#3 | 8.7%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice